CASTLE BIOSCIENCES, INC. Increase Decrease In Operating Lease Liability
CASTLE BIOSCIENCES, INC. (CSTL) reported Increase Decrease In Operating Lease Liability of -$231.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$59.00K.
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$172.00K.
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$209.00K.
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$197.00K.
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2025 was -$1.27M.
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2024 was -$1.29M, a 251.29% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2023 was $852.00K.
- CASTLE BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2022 was -$608.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$231.00K 10-Q · filed 2026-07-30 | -$440.00K derived: sum of 3 quarters · filed 2026-07-30 | -$637.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$172.00K 10-Q · filed 2026-05-06 | -$381.00K derived: sum of 2 quarters · filed 2026-05-06 | -$578.00K derived: sum of 3 quarters · filed 2026-05-06 | -$921.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$406.00K derived: sum of 2 quarters · filed 2026-02-26 | -$749.00K derived: sum of 3 quarters · filed 2026-07-30 | -$1.27M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$540.00K derived: sum of 2 quarters · filed 2026-07-30 | -$1.07M 10-Q · filed 2025-11-03 | -$1.49M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$343.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$869.00K 10-Q · filed 2026-07-30 | -$1.29M derived: sum of 3 quarters · filed 2026-07-30 | -$1.73M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$526.00K 10-Q · filed 2026-05-06 | -$952.00K derived: sum of 2 quarters · filed 2026-05-06 | -$1.38M derived: sum of 3 quarters · filed 2026-05-06 | -$1.56M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$426.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$857.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.04M derived: sum of 3 quarters · filed 2026-02-26 | -$1.29M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$613.00K derived: sum of 2 quarters · filed 2025-11-03 | -$863.00K 10-Q · filed 2025-11-03 | -$1.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$432.00K 10-Q · filed 2025-08-04 | -$673.00K derived: sum of 3 quarters · filed 2026-02-26 | -$538.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$250.00K 10-Q · filed 2025-05-05 | -$491.00K derived: sum of 2 quarters · filed 2026-02-26 | -$356.00K derived: sum of 3 quarters · filed 2026-02-26 | $670.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$106.00K derived: sum of 2 quarters · filed 2026-02-26 | $920.00K derived: sum of 3 quarters · filed 2026-02-26 | $852.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $1.16M derived: sum of 2 quarters · filed 2024-11-04 | $1.09M 10-Q · filed 2024-11-04 | $1.04M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $958.00K 10-Q · filed 2024-08-05 | $909.00K derived: sum of 3 quarters · filed 2025-02-27 | $795.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$68.00K 10-Q · filed 2024-05-02 | -$117.00K derived: sum of 2 quarters · filed 2025-02-27 | -$231.00K derived: sum of 3 quarters · filed 2025-02-27 | -$450.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$163.00K derived: sum of 2 quarters · filed 2025-02-27 | -$382.00K derived: sum of 3 quarters · filed 2025-02-27 | -$608.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$333.00K derived: sum of 2 quarters · filed 2023-11-02 | -$559.00K 10-Q · filed 2023-11-02 | -$773.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$445.00K 10-Q · filed 2023-08-02 | -$659.00K derived: sum of 3 quarters · filed 2023-08-02 | -$707.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$226.00K 10-Q · filed 2023-05-03 | -$440.00K derived: sum of 2 quarters · filed 2023-05-03 | -$488.00K derived: sum of 3 quarters · filed 2023-05-03 | -$783.00K derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | -$214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$262.00K derived: sum of 2 quarters · filed 2023-02-28 | -$557.00K derived: sum of 3 quarters · filed 2023-02-28 | -$852.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$343.00K derived: sum of 2 quarters · filed 2022-11-02 | -$638.00K 10-Q · filed 2022-11-02 | |
| 2021-06-30 | -$295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$590.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$295.00K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |